NCT03446040 2025-09-18An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have SpreadBristol-Myers SquibbPhase 1/2 Terminated92 enrolled 31 charts